Myriad Genetics, Inc.MYGNNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-25.4%
5Y CAGR-23.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-25.4%/yr
vs -7.6%/yr prior
5Y CAGR
-23.6%/yr
Consistent
Acceleration
-17.8pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.77 | -49.7% |
| 2024 | 1.53 | -28.3% |
| 2023 | 2.13 | +15.0% |
| 2022 | 1.85 | -35.3% |
| 2021 | 2.87 | -3.2% |
| 2020 | 2.96 | +92.3% |
| 2019 | 1.54 | -39.4% |
| 2018 | 2.54 | -21.3% |
| 2017 | 3.23 | +41.2% |
| 2016 | 2.28 | - |